Cita APA (7a ed.)

Wu, T., Ke, Y., Tang, H., Liao, C., Li, J., & Wang, L. (2021). Fidarestat induces glycolysis of NK cells through decreasing AKR1B10 expression to inhibit hepatocellular carcinoma. Elsevier.

Cita Chicago Style (17a ed.)

Wu, Tiangen, Yang Ke, Haoran Tang, Chen Liao, Jinze Li, y Lin Wang. Fidarestat Induces Glycolysis of NK Cells Through Decreasing AKR1B10 Expression to Inhibit Hepatocellular Carcinoma. Elsevier, 2021.

Cita MLA (8a ed.)

Wu, Tiangen, et al. Fidarestat Induces Glycolysis of NK Cells Through Decreasing AKR1B10 Expression to Inhibit Hepatocellular Carcinoma. Elsevier, 2021.